Gaetani M, De Giorgio R, Buratti P, Pasquali R, Capelli M, Stanghellini V, Corinaldesi R
Institute of Clinical Pharmacology and Therapy, St Orsola Hospital, University of Bologna, Italy.
Eur J Gastroenterol Hepatol. 1995 Mar;7(3):211-3.
To assess the effects of chronic oral administration of standard doses of lansoprazole on the luteinizing hormone pulsatile pattern and on follicle stimulating hormone (FSH) and testosterone levels in young men.
Eleven healthy volunteers were studied on three separate occasions, before and after two 3-week periods of treatment with lansoprazole (30 mg every morning) or a placebo, according to a randomized, double-blind, double-dummy, cross-over design. On each study day, blood samples were taken every 15 min for 8 h. The pulsatile pattern of luteinizing hormone, mean concentrations of FSH and total testosterone plasma levels were determined for each patient using specific radioimmunoassays.
Lansoprazole did not significantly affect mean plasma levels, the pulsatile pattern of luteinizing hormone, or mean plasma concentrations of FSH and testosterone compared with the placebo.
This study indicates that chronic oral administration of standard doses of lansoprazole does not affect the concentrations of gonadal hypothalamic pituitary or sex steroid hormones.
评估长期口服标准剂量的兰索拉唑对年轻男性促黄体生成素脉冲模式以及促卵泡激素(FSH)和睾酮水平的影响。
根据随机、双盲、双模拟、交叉设计,对11名健康志愿者在三个不同时间段进行研究,分别是在接受兰索拉唑(每天早上30毫克)或安慰剂治疗的两个3周疗程之前和之后。在每个研究日,每隔15分钟采集一次血样,共采集8小时。使用特定的放射免疫分析法测定每位患者促黄体生成素的脉冲模式、FSH的平均浓度以及血浆总睾酮水平。
与安慰剂相比,兰索拉唑对血浆平均水平、促黄体生成素的脉冲模式或FSH和睾酮的血浆平均浓度均无显著影响。
本研究表明,长期口服标准剂量的兰索拉唑不会影响性腺、下丘脑 - 垂体或性类固醇激素的浓度。